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ABSTRACT 
 
 
The Chronic Pain Center (CPC) in Saskatoon offers a multidisciplinary 
treatment program whose goals are to facilitate improved coping skills, function 
and well-being, and to promote self-reliant lifestyles.  They have documented a 
statistically significant improvement on several measures of physical and social 
functioning at the completion of the six week program, but to date have no formal 
evaluation of the long term effects. 
 
The purpose of this study was to re-evaluate the CPC clients (treatment 
group) at least one year following their completion of the treatment program to 
determine if they had maintained those improvements and also to compare them 
to the group of clients (control group) who underwent initial multidisciplinary 
assessment at the Centre, but did not attend the six week treatment program.  
Evaluation by mail out questionnaires assessed several important aspects of 
chronic pain.  A 34% response rate resulted in 142 participants for this study.  
 
Data analyses involved a multi-stage process of univariate, bivariate and 
multivariate analyses.  For the first goal, evaluating changes in the treatment 
group over time, the outcome variables considered  had been administered at 
three points in time: admission to the CPC program, discharge from the six week 
program, and at study follow-up.   For the second goal, the treatment and control 
groups were compared at one point in time; the study follow-up. 
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The study demonstrated that the scores on all outcome variables used in 
the follow-up study improved significantly from the time of assessment to the time 
of discharge for the clients who attended the CPC treatment program.  These 
improvements declined over time, but remained significantly improved from the 
admission scores.  (Wilks’ Λ=.501, F(1,48)=4.788, p=.000)  However, the study 
was unable to demonstrate any significant differences between the treatment and 
control groups on any of the outcome measures at the time of the study follow-
up.  (Wilks’ Λ=.930, F (1,107) = 1.014, p=.430) There were several limitations to 
this study, including the use of a non-randomized control group and the method 
of recruitment, which may have introduced bias into the study and affected the 
ability to effectively explain this finding.  
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Chapter 1 
 
Introduction 
 
 
1.1 Background 
Chronic pain, defined as pain that has been present three to six months or 
more, (1-3) is common and costly.  Surveys have indicated that between 17% 
and 29% of Canadians suffer from moderate to severe chronic pain, (1,2,4) and a 
report based on Statistics Canada 2001 Canadian Community Health Survey 
(CCHS-1.1) found 27.1% of men and 38.4% of women reported having at least 
one chronic pain condition.(5) The cost of medical expenses, lost income, and 
lost productivity in Canada is estimated at over $10 billion annually. (6)  This is 
not only a financial burden, but a difficult personal and social burden for many 
Canadians.  
Although no currently available treatment eliminates pain for the majority 
of patients, multidisciplinary pain rehabilitation programs have been shown in the 
literature to be beneficial and cost-effective for reduction of pain and improving 
functional outcomes. (7-11)  However, important gaps in the literature remain.  
There has been little research looking at the stability of improvement over time 
(12,13) and few studies have utilized comparison groups.  Those studies that did 
include a comparison group generally used individuals who were “drop-outs” of a 
program (14) or lacked insurance or the ability to pay for the program, (7,15) as 
the “no treatment” group.  The lack of clear outcome measures to determine 
success, (3,8,9,16) and poor response rates in follow-up have also been 
identified as problematic. (15,17)  
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1.2 Purpose and Research Questions 
The Chronic Pain Centre (CPC) in Saskatoon was established in 2004 as 
a publicly funded provider of multidisciplinary assessment and treatment for 
persons with chronic pain in Saskatchewan.  Of the 400 to 500 referrals received 
by the CPC each year, approximately 100 have been accepted annually for 
assessment, and of these, approximately 50 clients annually have attended the 
six week treatment program. The goals of treatment are to facilitate improved 
coping skills, function and well-being, and to promote self-reliant lifestyles.   
Preliminary findings, documented in a CPC internal report1, suggested that 
following this six week program, clients demonstrated statistically significant 
improvements on several measures of physical and social functioning.  These 
improvements appeared to be sustained when clients were re-evaluated three 
months after discharge from the program.  To date however, apart from internal 
statistical reviews, there has been no formal, more methodologically rigorous 
evaluation of the potential longer-term benefits of the CPC’s treatment program.   
The purpose of this study was to re-evaluate the CPC clients at least one 
year following their completion of the treatment program to determine if they had 
maintained improvements in function and social well-being and to compare them 
to the group of clients who underwent initial multidisciplinary assessment at the 
Centre, but did not attend the six week treatment program.  The specific research 
questions were: 
 
                                            
1 Personal communication: Kate Fast, Saskatoon Chronic Pain Centre, internal statistical review: 
2007 
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1)  Are improvements in clients physical and social functioning, observed 
at completion of the six week program, maintained over time? 
 
2)  Is there a significant difference in these outcomes, on evaluation at 
least one year after assessment, of those clients who completed the six 
week program compared to those who underwent the initial assessment, 
but did not attend the program? 
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Chapter 2:  
 
Literature Review 
 
 
2.1 Definition of Chronic Pain and Associated Features 
Pain is a complex, multi-dimensional experience that is difficult to describe 
or evaluate.  Chronic pain is defined as pain that has been present three to six 
months or more. (1-3) Although chronic pain may originate from an injury, in 
some individuals the pain persists beyond resolution of the underlying disorder 
and reaches a point where it interferes with normal function and everyday 
activity.  Chronic pain, though, includes factors other than just the defined 
duration of pain.  The pain is often more intense than the underlying process 
would predict (18) and it interferes with appetite, the ability to work, physical 
activity and sleep.  The pain becomes a preoccupation and can lead to fatigue, 
irritability and depression.  Fear of pain, fear of movement, and fear of re-injury 
can add to and complicate the perception of pain. (19) 
There is a large body of neuroscience research on chronic pain that is 
ongoing, and many experimental pain models have been proposed.  These 
models attempt to describe and delineate the components of chronic pain, 
including the nociception (the actual stimulation of nerves that conduct pain 
impulses), and the subjective response to pain which is filtered through an 
individual’s genetic composition, prior learning, psychological status, and 
sociocultural influences. (19)  These psychosocial factors involve both emotion - 
the immediate response to nociception, and cognition - the meaning attached to 
the emotional experience.  These emotional and cognitive factors can trigger 
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additional emotional reactions that amplify the experience of pain and perpetuate 
the vicious circle of nociception, pain, distress and disability. (19) 
Pain is ultimately a subjective experience, described in terms of sensory 
properties but incorporating many different emotions, primarily negative ones. 
Depression, anxiety, emotional distress and anger are common emotions in 
chronic pain patients. (19) For example, in a recent Canadian study, the 
prevalence of depression was twice as high among those reporting chronic pain 
compared to those who did not report chronic pain.  Depression was also related 
to pain intensity for both men and women, with higher levels of pain intensity 
being associated with higher prevalence of depression. (1)  Pain and emotion 
interact in many different ways and “emotional distress may predispose people to 
experience pain, be a precipitant of symptoms, be a modulating factor amplifying 
or inhibiting the severity of pain, be a consequence of persistent pain, or be a 
perpetuating factor.  Moreover, these potential roles are not mutually exclusive.” 
(19)  
A Canadian study (20) reported in 2008 that pain interfered with physical 
activity, recreation, family responsibilities and self-care, as well as impacted on 
the happiness and self-perceived health of pain sufferers.  Another study recently 
conducted at the University of Alberta’s Multidisciplinary Pain Centre in 
Edmonton reported a “significant disruption of attention and memory in two thirds 
of participants with chronic pain.”(21) Death by suicide appears to be at least 
doubled in chronic pain patients (22)  and it has been demonstrated in laboratory 
experiments “that uncontrolled pain compromises immune function, promotes 
tumour growth and can compromise healing. (23)  Not only does chronic pain 
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affect the individual, but also has consequences for the patients’ partner and 
family.  A study from the Netherlands demonstrated that chronic disease that 
involved pain and fatigue significantly impacted their partners’ personal life and 
social relations. (24) Chronic pain patients experience nociceptive dysfunction, 
anxiety, depression, anger, maladaptive behaviors such as catastrophizing and 
poor coping, as well as functional deficits and physical deconditioning.  These 
symptoms may also be interdependent, so treatment cannot simply address one 
of them.   Effective treatment programs need to address all these components 
and rely on appropriate and realistic goal setting and a collaborative 
interdisciplinary 2 treatment approach. (19,25,26) 
 
2.2 Epidemiology of Chronic Pain in Canada 
In Canada, chronic pain is more prevalent than other well-known chronic 
illnesses such as diabetes or asthma, affecting between 17% and 29% of 
Canadians.(27)  Another Canadian study found the average duration of pain was 
10.7 years, with an average intensity of 6.3 on a scale of 1 to 10. (2)  A study by 
the Alberta Ministry of Health and Welfare, based on data from the Alberta 
sample of the National Population Health Survey (NPHS) projected a 70% 
increase over the next 25 years in the number of Albertans suffering from chronic 
pain, primarily due to an aging population. (28) 
                                            
2 The term interdisciplinary is often used interchangeably with multidisciplinary, although they do have 
slightly different meanings.  Multidisciplinary team members work more independently and often 
sequentially and the primary means of communication may be the medical record.  Interdisciplinary teams 
are seen to work more collaboratively with frequent communication to discuss patient status and the 
evolving treatment as an integral part of the teams functioning. Having said that, these distinctions are not 
always adhered to in the literature and the terms are sometimes used interchangeably. (25) 
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According to data from the Canadian Community Health Survey, chronic 
pain is more prevalent in women (38.4%) than in men (27.4%), though the 
prevalence increases with age for both genders. (1,5)  Chronic pain is also 
associated with household income and marital status, with a higher prevalence 
among people in lower income categories and  those who are divorced or 
separated.(1)  A recent report based on Statistics Canada National Population 
Health Survey (1994/1995 through 2002/2003) and 2005 Canadian Community 
Health Survey Data examined chronic pain specifically in Canadian seniors. (20)  
The authors concluded that chronic pain is a “major health concern for seniors”, 
affecting 27% of seniors living in households and 38% of those in health care 
institutions. Similar to the general population of Canadians, older women are 
more likely to report chronic pain than older men, as are those with lower 
socioeconomic status. 
Estimating the economic burden of chronic pain is not straightforward.  
There are both direct and indirect costs to society. (29) The direct costs include 
medical costs, labour of health professionals, equipment and supplies used in the 
assessment and treatment of chronic pain.  The indirect costs include loss of 
potential productivity, both at home and at work (reduced work performance, 
absenteeism, unemployment) and reduction in health related quality of life.  In 
the United States, Turk et al estimated that the combined direct and indirect cost 
of chronic pain to be in excess of $125 billion US per year. (30) The exact cost of 
chronic pain in Canada is not known, but it is “believed to be enormous.” (31)  
The Chronic Pain Association of Canada estimates the annual cost to exceed 
$10 billion. (6) 
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2.3 Treatment of Chronic Pain 
The etiology of chronic pain is largely unknown, and as a result, treatment 
efforts have consisted of a wide variety of methods.  Because pain is a multi-
dimensional problem, and involves biological processes as well as cognitive, 
emotional and social components, (1,19,26) there is no single or quick solution. 
Chronic pain was first described as a disease in 1939 and following WWII 
the concept of multidisciplinary treatment was developed. The first 
interdisciplinary pain centers were established by the 1950’s and rapidly 
expanded over the next 20 years. (32)  Having said that, multidisciplinary pain 
management is still “often introduced at a very late stage” (3) or considered as a 
last resort when all other medical interventions have been tried and failed.(3,16) 
Initial efforts are generally aimed at eliminating the cause of pain, and when this 
fails, treatments including medication and physical modalities such as heat or 
cold are undertaken to palliate the symptoms or interrupt the transmission of pain 
signals.(10)  Physical therapy is often used in an effort to build or recondition 
muscles and improve functional mobility.  Other interventions may include TENS 
(transcutaneous electrical nerve stimulation), biofeedback, acupuncture, or 
therapeutic nerve blocks, which are local anesthetic injections administered to 
block the transmission of pain.  All of these interventions typically achieve only 
temporary pain relief with chronic pain patients.(9) During the course of this 
treatment, patients may be expecting a “cure”, and as their pain continues 
through these various approaches they may develop unhelpful coping strategies 
and maladaptive behaviors.(16,33)  
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Although there is considerable variation in the content of multidisciplinary 
or interdisciplinary programs in the treatment of chronic pain, they generally have 
at least three different medical specialists or health care providers involved. 
(3,27)  Interdisciplinary team members usually include a physician, nurse, 
psychologist, physical therapist, and an occupational therapist.  Communication 
and collaboration among the team members is a vital part of this treatment 
method.  The goal of treatment is not necessarily to improve the pain, but rather, 
to improve the coping skills and function of someone living with chronic pain. 
(34,35)  The focus of an interdisciplinary program is on addressing barriers 
specifically related to pain – fear of re-injury, catastrophizing, poor sleep and lack 
of understanding about safe and necessary reactivation.  This is in contrast to 
“Functional Restoration” programs, which tend to focus on physical conditioning 
and work hardening (reconditioning to specific job tasks to transition from 
treatment to return to work).  As commented by Stanos, “Interdisciplinary pain 
programs provide outcome-focused, coordinated, goal-oriented interdisciplinary 
services.” (25) 
While the actual reduction in intensity of pain may be minimal, (7) it is 
apparent that other criteria are important in the evaluation of effectiveness of 
treatment.  Which is considered the most important change may depend on the 
perspective of the individual client. (17)  Over the past 20 years, research has 
provided a substantial body of evidence supporting the effectiveness of a 
multidisciplinary approach to treatment of chronic pain. (7,8,10,14,16,36)  These 
studies have reported improvement in function and lifestyle, and at the very least, 
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chronic pain clients broaden their range of coping strategies and recognize that 
they are not alone.   
Due to the rapidly increasing number of pain clinics, the question of 
effectiveness of multi-disciplinary treatment approaches has been studied 
extensively.  Flor et al (7) conducted a meta-analysis of many of the early 
studies, looking at 65 studies published from 1960 to 1990.  They found 
multidisciplinary treatments superior to no treatment, being on a waiting list and 
single discipline treatments.  The study identified numerous benefits of 
multidisciplinary treatment including improvements in pain, mood, pain 
interference (interfering with activity and daily living), return to work and 
decreased use of the health care system, and these benefits appeared to be 
stable over time, although they defined long-term as over six months.  Flor et al 
was one of early authors to establish the effectiveness of a multi-disciplinary 
approach to chronic pain management, and this finding has been supported by 
more recent literature as well.  In 1999, Morley et al, (8) looked at published 
reports of randomized controlled trials of cognitive behavior therapy for chronic  
pain, and found “good evidence” for its effectiveness, and Turk et al (9) in a 2002 
literature review, examined published studies to compare the clinical 
effectiveness and cost effectiveness of treatments for chronic pain.  Turk found 
that pain rehabilitation programs demonstrated comparable reduction in pain to 
alternative treatments (including medication, conservative care, surgery, spinal 
cord stimulators and implantable drug delivery systems) but “with significantly 
better outcomes for medication use, health care utilization, functional activities, 
return to work, and closure of disability claims.”  They also found “substantially 
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fewer iatrogenic consequences and adverse events.”  These studies have 
provided a strong basis for the use of multidisciplinary pain management 
programs as the best therapeutic option for treatment chronic pain patients. 
There has continued to be great interest in evaluation of not only the 
effectiveness of this approach to managing chronic pain but also examining 
various aspects and components of treatment.  Robbins et al (14), in their study 
examining the efficacy of treatment in an interdisciplinary pain management 
centre, made comparisons between treatment program completers and treatment 
dropouts. They showed no statistically significant difference between these two 
groups at pre-treatment but found that patients who completed the 
interdisciplinary pain management program “demonstrated significant 
improvement on the majority of outcome measures”, and maintained these gains 
at one-year follow-up.  A study evaluating the effects of a multidisciplinary pain 
management program on coping, health related quality of life and pain intensity 
(34) found significant improvements related to coping, avoidance, pain intensity, 
global mental health as well as social and physical functioning.  Mead et al (16) 
did pre-test and 6 week follow-up evaluation on participants of a Pain Coping 
Strategies Program and reported statistically significant decreases in anxiety, 
improvement on the physical tests and improvement on their perceived 
performance and perceived satisfaction of activities of daily living.  Recently a 
study conducted in Norway (37) compared the outcomes of a chronic pain 
rehabilitation program to an age-matched comparison group from the general 
population in the same geographic area.  They found significant improvement in 
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function, although the participants still reported significantly lower function on all 
core aspects of functional health status compared to the normative sample. 
This body of research suggests that multidisciplinary programs may be the 
most effective treatment for chronic pain.  However, several limitations in 
studying chronic pain management have been discussed in the literature: the 
unsystematic use of outcome measures, lack of control or comparison groups, 
poor response rates to follow-up and lack of long-term evaluation (ie. over 18 
months). (10,13) These issues are discussed in the sections that follow. 
 
2.3.1 Unsystematic Use of Treatment Outcomes 
One of the challenges identified in the literature is that there are no clear 
outcome measures to determine success in the treatment of chronic pain. 
(3,8,9,16)  In a systematic review of 25 studies, there were a total of 221 
outcome measures used, the majority being self-reported. (8)   On the one hand, 
there is a need for use of measures which accurately reflect the multifaceted 
nature of pain.  As Turk states, “pain is not a monolithic entity…Since there are 
many facets to pain, it should be obvious that no single outcome measure 
captures all of the relevant issues.  For this reason, outcome assessment must 
look at a variety of criteria to adequately describe the effects of any treatment.”(9)  
But on the other hand, the wide variety of measures makes integration of the 
research on treatment effectiveness a challenging task. Use of a standard set of 
outcome measures for chronic pain would facilitate comparisons of the 
effectiveness of chronic pain treatment programs. 
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To address these challenges, systematic reviews have grouped the most 
commonly used outcome measures into “domains”. (3,8,10)  In 2002, in an effort 
to standardize the domains, a consortium of 27 professionals with expertise 
relevant to evaluation of chronic pain treatment outcomes met in the U.S.  Those 
involved in this “Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials” (IMMPACT) (38) were selected to represent health care 
disciplines, academia, governmental agencies and the pharmaceutical industry.  
Their goal was to make recommendations for which core outcome domains 
should be considered by investigators conducting clinical trials of the efficacy and 
effectiveness of treatments for chronic pain.  They identified six core domains: 
pain intensity, physical functioning, emotional functioning, participant ratings of 
improvement, symptoms or adverse events, and participant disposition 
(adherence or withdrawal). They recommended that each of the six domains 
should be considered in the design of all clinical trials of the efficacy and 
effectiveness of treatments for chronic pain, and if one or more are not included 
the reasons for exclusion should be justified a priori.  IMMPACT met again in 
2003 to recommend core outcome measures for each of these domains.(39)  In 
2006, IMMPACT met, this time with 40 participants from universities, government 
agencies, a patient self-help organization and the pharmaceutical industry to 
determine the clinical importance of changes in each of the specific outcome 
measures previously recommended.(40)  The core domains suggested by 
IMMPACT are consistent with the OMERACT-III (41) (Outcome Measures in 
Rheumatoid Arthritis Clinical Trials) which have been adopted by the World 
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Health Organization /International Leagues of Associations for Rheumatology 
(WHO/ILAR). (42) 
 
2.3.2 Inadequate Control Groups and Poor Response Rates 
A second limitation identified in the literature is that few studies utilized 
comparison groups. (3,7,15,16,43) A suggested justification for this was that 
since the subjects had long histories of pain, a change following the short interval 
of treatment could logically be attributed to the treatment.(17)  In studies that did 
use a comparison group it has been suggested that they were rarely appropriate. 
(7,8,43) Robbins et al (14) used “program drop-outs” as a control group finding 
that those who completed the interdisciplinary pain management program 
demonstrated significant improvements on the majority of outcome measures 
relative to the “drop-outs.” 127 subjects completed the program and 74 dropped 
out for various reasons including noncompliance (78.4%).  Deardorff et al (15) 
used lack of insurance authorization for the treatment program as the “no 
treatment” group.  They found positive outcomes of increased physical 
functioning, decreased medication use, and increased return to work rate for the 
treatment group compared to the no-treatment group.  They did note that as well 
as the lack of insurance, the no-treatment group was “significantly older” than the 
treatment group and had a greater proportion of males than females.  Roberts 
and Reinhardt (44) used a comparison group made up of patients who had been 
rejected for treatment, or refused to attend.  Reasons for rejection included such 
things as unwillingness to cooperate, severe medical problem, severe mental 
disorder or chemical dependency as the primary problem.  Guck et al (45) used a 
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no-treatment group made up of patients who had been accepted for treatment 
but lacked the financial ability or insurance coverage to pay for the treatment 
program.  Several studies used wait-lists, but these were short term, as ethically 
a wait list can only be maintained until a place opens up in the treatment 
program. (8)  
In those studies that did use a comparison group they were not randomly 
assigned, and often were self-selected.  The importance of a control or 
comparison group, and random assignment, is in the ability to show a causal 
relationship. (46) The use of a randomized control group allows the researcher to 
conclude, with more confidence, that any change observed in the treatment 
group can be attributed to the treatment itself and not to some extraneous 
factors. An important assumption is that the treatment and comparison group are 
alike on all factors which may be associated with the outcome of interest, except 
for the treatment itself.  Therefore, a systematic difference, such as the ability to 
pay or the reason for a patient or group of patients dropping out or being 
excluded, may introduce bias into the findings.(3)  The difficulty in designing 
suitable controls has been discussed in many articles. (8,16,47) Hildebrandt (47) 
states that “a randomized control group would have been very difficult, if not 
impossible” and Morley, (8) in his systematic review, states that “the variety of 
control conditions reflect the difficulty in designing suitable controls.”  He goes on 
to state that “being allocated to a control would have different psychological 
consequences to being allocated to an active treatment.”   
  Poor response rates to follow-up have been identified as a problem issue 
as well, (15,17) and it has been reported that “it is not unusual for follow-up 
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evaluation to be based on less than 30% of the original  population.” (17) This is 
a difficult population to engage.  Low response rates can introduce bias into a 
study if “responders” differ in a systematic way from the “non-responders.” (48) 
For example if they differ with respect to their sex, age, medical characteristics, 
or even a factor that is not obvious or assessed.  Nonresponse bias can lower 
the statistical power of the study and mask statistically significant relationships, 
which “truly” exist. (49) Nonresponse can also limit the generalizability of the 
findings.  
Turk (17) goes on to say that outcome research in this area is a “daunting 
task” and the “perfect treatment outcome study is not only inconceivable, but it 
would surely be impossible to execute,” but that we should not be deterred from 
continuing to evaluate the effectiveness of treatment in chronic pain.  Gamsa 
adds that the problems are complex and difficult to solve and it “may be 
necessary to accept limits in a field of study defined by multiple interacting 
variables.” (43) 
 
2.3.3 Lack of Long Term Follow-up 
In reviewing the literature, it is noted that there is very little data on long 
term effects of these programs. In fact, there is no standard definition of what 
long term means, and in an early meta-analysis, Flor et al (7) divided the 65 
studies reviewed into “short term”, which was up to six months after completion 
of treatment, and “long term” which was defined as longer than six months post 
treatment.  Turk and Rudy (50) conducted a literature review of “many studies”, 
the majority citing a one year follow-up period.  McCracken and Turk (10) 
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conducted a literature review, which included several meta-analyses, and 
concluded that “there was little data beyond 18 months.” 
Many studies look at immediate effects following the intervention.  A 2004 
study (34) evaluating the effectiveness of a multidisciplinary pain management 
program used data collected only before and immediately after the treatment 
program, and Mead et al, (16) in 2007, used data from pre-treatment and six 
weeks post program.  Moss-Morris et al (36) used a longitudinal design 
evaluating patients at the end of a four week treatment program and at one, three 
and six months.  It is common in the literature to use six and/or twelve month 
follow-up periods for evaluation of outcomes. (14,34,47,51,52) 
There is considerable evidence that improvements are maintained for up 
to one year.  In a 1991 study, Deardorff (15) compared a group of patients 
treated in a multidisciplinary pain program to a group of patients who were 
evaluated by the program, but not included in the treatment program due to lack 
of insurance coverage.  The average time to follow-up was approximately 10 
months for the treatment group and approximately 13 months for the non-
treatment group.  The findings supported the effectiveness of the treatment 
program showing increased physical functioning, decreased medication use, and 
an increased return to work rate for the treatment group. Robbins et al (14) 
conducted a prospective one-year outcome study of interdisciplinary chronic pain 
management.  Patients were compared pre and post treatment as well as at one 
year follow-up evaluation.  Comparisons were made between “treatment program 
completers and treatment dropouts.”  Their results “clearly show” that patients 
who completed the interdisciplinary program demonstrated significant 
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improvements on the majority of outcome measures and maintained these gains 
at follow-up, relative to the treatment dropouts. 
A recent study evaluated patients before, after and at 12 months following 
treatment to determine how treatment expectancy affects the outcomes of 
treatment.  In this study they defined long-term outcomes as 12 months. (51) All 
of these studies supported the effectiveness of a multidisciplinary approach to 
management.   
However, there has been some suggestion that the positive effects of a 
treatment decline over time.  Harkapaa, in a 1990 study from  Finland, (53) 
showed positive results three months after a multidisciplinary program for chronic 
low back pain, but found these effects had “faded out” in many of the measured 
parameters  after one year.  They found a “refresher” program offered one and a 
half years after the initial program was effective in restoring the improvements.   
Lanes et al (12) contacted patients whom had completed a multidisciplinary 
rehabilitation program for chronic back pain within a previous ten year period and 
interviewed 52.9% of these patients. The length of time since completion of the 
program ranged from .2 to 9.7 years, the average being 3.1 years.  Although their 
findings supported the effectiveness of this approach to treatment in terms of 
return to work, they found a general decline in the percentage of patients 
reporting feeling better than before treatment as they moved to longer term. (75% 
of those less than six months post treatment compared to 38% of those who 
were more than three years reported feeling better or much better than before 
treatment)  Bendix et al (54) investigated four different types of back pain 
treatments over a five year period.  They found positive results related to return 
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to work, less sick time, less health care usage, and coping better in daily 
activities in the treatment group compared to a control group after four months 
and one year, but also found that some of these positive benefits had “faded out” 
at the two year evaluation.  These longer term follow-up studies, all finding 
support for a multidisciplinary approach to treatment but some decline in positive 
effects over time, were specifically for chronic back pain programs. 
Moss-Morris et al (36) examined the patients’ perceptions of their pain 
across a multidisciplinary pain management program, evaluating them at the 
beginning and end of the four-week treatment program and at one, three and six 
months follow-up.  They showed that a multidisciplinary pain program is 
successful in improving pain-related disability and reported gains in both mental 
and physical wellbeing, but also found a small loss in treatment gains over the 6 
month follow-up period.  A prospective study from Norway (55) used data from a 
one year follow-up evaluation, and suggested that future studies should “clarify 
the long-term effect of multidisciplinary rehabilitation programs for individuals with 
chronic musculoskeletal pain in terms of function in daily life.”  
 
2.4 Implication of Literature Review for the Present Study 
In the present study, an attempt was made to contact all clients who were 
assessed at the Saskatoon Chronic Pain Centre (CPC) for follow-up at least one 
year after their final contact with the CPC, and for some this was over three years 
following their contact with the CPC.  This is a longer follow-up time than is 
generally found in the literature. 
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In order to facilitate integration with the literature, the follow-up evaluation 
in this study addressed the domains recommended by the IMMPACT group and 
included a measure of pain intensity, physical functioning, emotional functioning 
and overall improvement. 3  The goals of the treatment program – improved 
coping skills, function and well-being and the promotion of self-reliant lifestyles 
are captured in the domains of physical and emotional functioning and overall 
improvement.  Although actual reduction of pain is not necessarily a goal of 
treatment, it is important to monitor and has been included in the evaluation. 
Outcome measures that were recommended for each domain included: a pain 
severity visual analogue scale (VAS), the Multidimensional Pain Inventory (MPI), 
the Beck Depression Inventory (BDI-II) and the Patient Global Impression of 
Change (PGIC).  The first three of these had previously been used by the CPC 
for evaluation of the treatment group during the six week CPC program, and thus 
provided a basis for comparison for this group in the follow-up evaluation.  
As identified in the literature, comparison groups are difficult to establish 
effectively in this population.  Although randomization is considered the “gold 
standard”, when it is not deemed possible, a non-random control group may be 
used, although this offers less compelling support for causation. (46) By 
definition, a quasi-experimental design lacks random assignment, with 
assignment to conditions being by means of self-selection. (46) Because of this, 
the investigator must rely on other design options to reduce internal validity 
threats. (46) This study used a non-randomized control group (for the second 
                                            
3 The other two recommended domains; symptoms or adverse events, and participant disposition 
(ie. withdrawal) are specific to drug clinical trials and not applicable to this study. 
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research question) which is a stronger design than many previous studies, and 
was further strengthened with additional study design considerations.  In an effort 
to improve postal response rates for this study, a number of strategies reported 
in the literature were employed including reminder letters and the use of colored 
questionnaire paper.   
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Chapter 3: 
Methodology 
 
3.1 Background 
The Chronic Pain Centre (CPC) was established in Saskatoon in May 
2004, and the goal of this six week program is to facilitate improved coping skills, 
function and well-being, and to promote self-reliant lifestyles.  Data collected by 
the CPC at the pre-assessment and assessment stages were made available for 
this study in addition to the data collected by questionnaire specifically for the 
study. 
 
3.1.1 Data Source 
Between its inception in 2004 and October 2007, the CPC had conducted 
approximately 400 multidisciplinary assessments and provided treatment for 
approximately 200 clients.  Approximately 400 to 500 initial referrals are received 
each year at the CPC from family practitioners. (Figure 3.I) These referrals are 
screened and those patients who would be better managed by an alternate 
resource are re-directed. (ie palliative, frail geriatric, acute pain, cancer)  Once 
past the initial screening, clients are asked to complete a pre-assessment 
questionnaire recording demographic characteristics, pain information, medical 
and social history, basic psychosocial information and self-reported functional 
status. (Appendix 7.1)  Approximately 100 of these clients are scheduled 
annually for an in-person multidisciplinary assessment session.  Following this 
assessment, clients are invited to attend the six week chronic pain management 
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program.  In this study, the clients who were assessed and attended the six week 
treatment program (described below) constitute the “treatment group”, and the 
clients who were assessed but did not attend the program are the “control 
group”. 
 
Figure 3.1: Referral Process for the CPC: 
 
 
       
 
 
 
 
3.1.2 The Saskatoon CPC Treatment Program 
The Saskatoon CPC treatment program is based on a cognitive-
behavioral approach and consists of education sessions, discussion/support 
groups, physical activity and individual and group sessions with a psychologist, 
physical therapist, occupational therapist, nurse and physician.  Although all 
clients participate in the complete program and all services, the treatment 
program is tailored to meet each individual’s needs in order to reach their 
treatment goals.   
The assessment team is comprised of a medical consultant, a 
psychologist and a registered nurse.  A physical therapist and occupational 
therapist are available to take part in the assessment when appropriate.  Their 
findings are combined and summarized in an “Assessment Report” that identifies 
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referrals from 
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-onset, cause, 
location of pain 
Pre-
Assessment 
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VAS, general 
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program offered: 
-approximately half of 
them accept and 
attend. 
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medical and psychological barriers to recovery and makes recommendations for 
both pain medication optimization and rehabilitation. 
The six week program includes daily attendance at the CPC for 3 1/2 
hours for the first four weeks, and then a one week break to provide an 
opportunity to practice the pain management skills at home and assess problems 
that the clients may encounter.  This is followed by a return week to review and 
problem solve with the treatment team to promote success after discharge. The 
six week program is focused on teaching skills that enhance self-management of 
pain. Typically a client would receive ten sessions of physical therapy, five 
sessions with the occupational therapist, and five with the psychologist, as well 
as weekly group activity and discussions.  Regular physical activity is 
encouraged in the program.  Additionally, clients are taught specific coping 
strategies, such as rational self-analysis, diaphragmatic breathing, relaxation 
techniques and pacing.  Interdisciplinary case conferences are held weekly, and 
typically each client’s case is discussed in this conference on three occasions.  
The first meeting is held immediately following the initial evaluation by the 
assessment team to discuss if the client is a good candidate for the program and 
to identify preliminary treatment goals.  The remaining meetings are held at the 
mid-point of the program and at discharge to discuss client progress.  
During the course of the program, the clients complete a number of 
psychosocial and functional measures, both at the beginning and at the 
completion of the six week program.  These measures include: the Beck 
Depression Inventory (BDI-II), the Multidimensional Pain Inventory (MPI), Tampa 
Scale (fear of movement), Pain Catastrophizing Scale, and the Chronic Pain 
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Acceptance Questionnaire (CPAQ-R).  Following discharge, there is a voluntary 
three month review in which clients are asked to complete the same measures 
for a third time. The CPC also conducts annual focus groups with clients, as well 
as satisfaction surveys of clients and family physicians and reports that based on 
a 100% response rate of the client satisfaction survey, 90% of clients felt “more 
capable and confident” of managing their condition and 95% of the physicians 
who have referred a client to the CPC were satisfied with the program. 
 
3.2 Recruitment Procedure for Follow-up in This Study: 
Clients were considered eligible for the study if they had undergone the 
assessment at the CPC prior to October 2007.  Due to “privacy” concerns, the 
initial contact with all CPC clients was done by personnel hired by the Saskatoon 
Health Region who contacted eligible clients by phone to explain the study, ask if 
they would be willing to participate and obtain consent.  Attempts were made to 
contact all clients who had been assessed at the CPC between its inception in 
2004 and October 2007.  Unfortunately, virtually all of the contact phone calls 
were made during regular working hours.  (8:00 A.M. to 6:00 P.M.) 
Questionnaires were mailed out to all clients who agreed to participate and a 
number of strategies were used that have been identified in the literature as 
effective in increasing response rates to postal questionnaires. (49,56-59) These 
strategies included a pre-mail out telephone call, stamped return envelope, and 
the questionnaire printed on pink colored paper.  The main questionnaire, 
including a cover letter, (Appendix 7.2) was followed with a reminder letter one 
month later, and in another month, non-responders were sent a reminder letter 
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with a second copy of the questionnaire and a pen.  A third wave was a second 
reminder letter for non-responders. 
Finally, an incentive for participation was offered.  To ensure that subject 
responses remained anonymous, the entry form was completed by the client and 
sealed in an envelope prior to being returned with the questionnaire.  On receipt 
of the completed questionnaire, the sealed envelope containing the name of that 
client was removed and entered into the draw box for a participation prize. 
 
3.3 Instrumentation and Study Variables 
Following the guidelines recommended by the IMMPACT consensus, and 
to reflect the goals of the treatment program, the follow-up evaluation for this 
study included measures to address the domains of pain intensity, physical 
functioning, emotional functioning and overall improvement.  The IMMPACT 
group had also made recommendations for the core outcome measures to be 
used to determine the effectiveness of treatments for chronic pain.  In this study, 
for each domain evaluated, one of the recommended outcome measures was 
selected.  To provide an opportunity for further comparison for the treatment 
group, the outcome measures selected were those which had previously been 
used by the CPC with the clients who had attended the six week program.  An 
additional consideration in instrument selection for the study was participant 
burden, especially in light of the fact that response rates are already an identified 
challenge.  Please refer to Appendix 7.2 for the complete questionnaire used in 
this study. 
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3.3.1 Dependent Variables 
Pain intensity was measured with a visual analogue scale (VAS) which 
consists of a 10-cm horizontal line with hash marks at one-centimeter intervals.  
Clients were asked to indicate where on the scale, from “No Pain” (0 cm) to 
“Worst Possible Pain” (10 cm) best described their level of pain in the last 24 
hours.  Scores can range from 0 to 10, with higher scores indicating worse 
perceived pain.  The VAS has been found to be a valid and reliable instrument 
(60,61) and well established in the chronic pain population with test-retest 
reliability correlations between .75 and .83. (37)  
The Multidimensional Pain Inventory (MPI) is a comprehensive 60-item 
self-report inventory, designed to measure several important aspects of the 
subjective experience of chronic pain, including pain intensity, emotional distress 
and cognitive and functional adaptation in response to their condition.  (62) The 
MPI was developed as a multidimensional assessment instrument, theoretically 
linked to the cognitive-behavioral perspective of pain, and specifically for use with 
chronic pain patients. (62) In its entirety the MPI consists of 12 scales, grouped 
into 3 sections: 1) pain and its impact, 2) responses by significant others, and 3) 
activities.  Sample items include: “In general, how much does your pain interfere 
with your day-to-day activities?” and “How much control do you feel that you 
have over your pain?”  Clients are asked to respond to questions based on a 
scale from 0 to 6, with 0 being “Never” or “Not at all” and 6 being “Very Much”, 
“Very Often” or “Extreme”.   The scores are computed by the MPI computer 
program into a raw score and a t-score for each of the scales.  To be consistent 
with the data already collected by the CPC, five MPI scales were used in this 
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follow-up: Pain Severity, Interference, Life Control, Affective Distress and 
Support, as well as the scale for General Activity. For Pain Severity, Interference 
and Affective Distress, a higher score indicates increased symptoms or more 
difficulty related to these scales as opposed to Life Control, Support and General 
Activity where a higher score would indicate improved status or less difficulty.  
The MPI is reported to be psychometrically sound; the reliability (internal 
consistency) estimates for all scales ranging from .70 to .90. (62) The MPI has 
been widely used as an outcome measure and its psychometric adequacy has 
been demonstrated in diverse types of chronic pain. (40)  It provides a reliable 
and valid measure of the interference of pain with physical functioning. (39) 
The Beck Depression Inventory (BDI-II) (63-65) is a 21 item self-report 
scale assessing severity of symptoms of depressive disorders. The BDI consists 
of items with four statements rated from 0 to 3 in terms of intensity.  Clients are 
instructed to select the statement which best describes their own feelings.  For 
example, the statements related to “Sadness” are 0 = I do not feel sad, 1 = I feel 
sad much of the time, 2 = I am sad all the time, and 3 = I am so sad or unhappy 
that I can’t stand it.  Total scores range from 0 to 63, with higher scores indicating 
increased symptoms of depression.  Estimates of the BDI’s internal consistency 
reliability (Cronbach’s alpha) range from .73 to .95, (40,66)  and test-retest 
reliability (Pearson) at .80 to .90. (40)  The brevity and low reading level 
requirements are considered additional strengths of this instrument. (40) 
  The Patient Global Impression of Change scale (PGIC) is a single-item 
rating for overall assessment of change. (67) Respondents select one statement 
from a seven point scale ranging from 0 (“very much improved”) to 7 (“very much 
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worse”).  The PGIC has shown sensitivity to change and is “extensively used by 
pain researchers as a standard outcome measure and for comparison to other 
outcome measures.” (68) This measure is intended to provide an indication of the 
clients’ overall impression of change, and the meaningfulness of this change, or 
the personal importance that the change has for participants. (38)  There is 
widespread use of the PGIC in clinical trials, and the data has been reported to 
provide “a responsive and readily interpretable measure of participants’ 
assessments of the clinical importance of their improvement or worsening over 
the course of a clinical trial.” (39,40)  The measure has been criticized due to the 
reliance on the client recalling their initial state and mentally comparing it to the 
present, but in spite of this it is thought to be valuable to include one rating of 
global improvement to assess the client’s personal perspective. (38) 
 
3.3.2 Other Variables 
Several variables were used from the pre-admission data provided by the 
CPC.  Age, gender, educational status, pre-admission VAS and area of pain 
information were available for both study participants and non-participants.   For 
the pre-admission VAS, all clients had been asked during the CPC pre-admission 
assessment to rate the level of pain during the past 24 hours.  The area of pain, 
self reported as the primary complaint, was defined as musculoskeletal, 
neuropathic, abdominal, headache, incisional, pelvic, other and unknown.  
Information was also available to construct two additional variables: 1) time since 
assessment at CPC (the time in months between the initial assessment at CPC 
and contact for the study follow-up) and 2) time since treatment start (the time 
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between the actual start date of CPC treatment program and follow-up contact 
for those clients who attended the program). 
An additional two questions were included in the study questionnaire, the first 
regarding employment status and the second asking about any other treatments 
that have been sought since the CPC visit. 
 
3.4 Ethical Approval 
Ethical approval was obtained from both the Behavioural Research Ethics 
Board (Beh-REB) of the University of Saskatchewan and Ethics Committee of the 
Saskatoon Health Region. (Appendix 7.3) Verbal consent was obtained from 
each participant at the time of phone contact, when they agreed to participate in 
the study.  Two copies of the consent form (Appendix 7.4) were also sent out 
with the questionnaire package; one for their reference and one returned signed 
with the questionnaires.  
 
3.5 Analysis  
 Data analyses involved a multi-stage process consisting of univariate, 
bivariate, and multivariate analyses using SPSS 17.0 for Windows.  The 
particular variables used in the analysis varied according to the research 
question. (Table 3.1)  
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Table 3.1: Summary of Variables used in Follow-up Questionnaire, by Research 
Question. 
 
 Research  
Question 1 
Research 
 Question 2 
Dependent Variables   
Visual Analogue Scale (VAS)  ■ 
Multidimensional Pain Inventory (MPI)   
Pain Severity ■ ■ 
Interference ■ ■ 
Life Control ■ ■ 
Affective Distress ■ ■ 
General Activity  ■ 
Beck Depression Inventory (BDI-II) ■ ■ 
Patient Global Impression of Change Scale (PGIC)  ■ 
Other variables   
Age ■ ■ 
Gender ■ ■ 
Education level ■ ■ 
Employment status4 — — 
Pre-admission VAS ■ ■ 
Area of pain ■ ■ 
Time since assessment at CPC5  ■ 
Time since treatment at CPC ■  
Further treatment sought after CPC ■ ■ 
 
 
3.5.1 Preliminary Analysis 
Preliminary data analysis included data screening and the testing of 
statistical assumptions.  Any outliers were checked in the raw data, and were 
corrected if found to be data entry errors.  When testing basic assumptions, it 
was found that some of the outcome variables were not normally distributed.  
These variables were subsequently transformed (squared or cubed to reduce a 
                                            
4 Subsequent to data collection, it was found that data related to the question about employment 
were not specific enough to be useful, and therefore were not used in the analysis. 
 
5 time since assessment categorized by less than the median/more than the median of 32 months 
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negative skew and square root transformed for a positive skew)(69) and 
rechecked for normality.  
The data on the total group of clients that were eligible for the study were 
examined, and comparisons were made between those clients that participated 
in the study and those that did not participate in this study. Differences between 
these groups were tested using chi-square tests for categorical variables and t-
tests for continuous measures. 
 
3.5.2 Analysis for Research Question 1 
Are improvements in clients physical and social functioning, observed at 
completion of the six week program, maintained over time? 
 
To evaluate changes in the treatment group over time, the outcome 
variables uses for analysis were the BDI and four MPI6 scales: Pain Intensity, 
Interference, Life Control and Affective Distress.  These variables had been 
collected at three points in time (Figure 3.2): admission to CPC treatment 
program (Time 1), discharge from CPC program (Time 2) and at data collection 
for follow-up for this study (Time 3).  Although the Time 3 follow-up 
questionnaires were collected at one point in time, the actual length of time 
between Time 2 and Time 3 varied for individual participants from one to three 
years.  
                                            
6 In review of the data collected, it was noted that one of the scales within the MPI (Support) had 
a considerable amount of missing information.  This scale was questioning whether or not the 
client had support of a spouse or significant other, and in the questionnaire there was an 
opportunity to select a “not applicable” answer.  In addition there were also several “missing” 
answers in these questions.  As a result this scale was not included in the analysis. 
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Figure 3.2: Question 1: Treatment Group Testing Times. 
 
 
 
 
 
In preliminary examination of the data,  paired samples t-tests were used 
to examine changes in the scores over the three points of time by comparing  the 
means of each variable for Time1 to Time 2 (admission to discharge), Time 2 to 
Time 3 (discharge to follow-up) and Time 1 to Time 3 (admission to follow-up).  
The paired t-test compares the means of two variables by computing the 
difference between the two variables for each case, and testing to see if the 
average difference is significantly different from zero.   
To take into account multiple dependent variables, a multivariate analysis 
of covariance (MANCOVA) was then conducted to examine the treatment 
groups’ scores on the various outcome measures at the three points in time.  The 
MANCOVA compares the differences in the means between the different time 
points, therefore, “difference scores” were computed and comparisons were 
done looking at Time 1 to Time 2 (admission to discharge), and Time 1 to Time 3 
(admission to follow-up).  The MANCOVA was repeated using an alternate 
method, with the Time 1 scores entered as covariates rather than using the 
difference scores. 
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Results of the univariate tests were then examined to provide additional 
information about the significant multivariate result and how it affected the 
dependent variables. 
 
3.5.3 Analysis for Research Question 2 
 Is there a significant difference in these outcomes, on evaluation at least 
one year after assessment, of those clients who completed the six week 
program (treatment group) compared to those who underwent the initial 
assessment, but did not attend the program (control group)? 
 
To address the second research question, both the treatment and control 
groups were considered at one point in time - the study follow-up period of at 
least one year since assessment.  (Figure 3.3) 
 
Figure 3.3: Question 2: Comparison of Treatment and Control Groups. 
 
  
 
 
 
 
 
The treatment and control groups were compared on the eight outcome 
measures: the VAS, BDI, the PGIC (Global Change), and five scales of the MPI; 
Pain Severity, Interference, Life Control, Affective Distress and General Activity. 
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Given the lack of random assignment to treatment condition, it is important 
to establish that the treatment and control groups are alike as possible on 
characteristics which may potentially impact the outcomes of interest in this 
study.  To that end preliminary analysis for Research Question 2 involved 
comparing the treatment and control groups on demographic information, CPC 
pre-admission data and time since assessment.  Differences between the 
treatment group and control group were tested using chi-square tests for 
categorical variables and t-tests for continuous measures.   
In preliminary examination of the data a series of one-way ANOVA’s was 
conducted, to examine the means and standard deviations of the treatment and 
control groups on each outcome variable.  The next step was a multivariate 
analysis of covariance (MANCOVA), which is designed to look at several 
dependent variables simultaneously, include covariates and also look at 
interactions between independent variables.  In addition to considering main 
effects, particularly treatment group status, the MANCOVA is also able to test 
whether treatment status interacted with other variables (e.g. time since initial 
assessment, gender, etc) to influence any of the dependent variables. Results of 
the univariate tests were then examined to provide additional information about 
the significant multivariate result and how it affected the dependent variables. 
 
The VAS had been measured at the pre-assessment stage as well as the 
follow-up for all study participants; therefore an exploratory analysis, using paired    
t-tests, was conducted separately for the treatment and control groups to 
examine changes in this pain severity rating; an ANOVA was then used to 
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examine the difference scores, representing the change in the VAS over time, 
based on treatment status. To further compare the treatment and control groups 
on the follow-up VAS, a univariate analysis of covariance (ANCOVA) was 
conducted, using the pre-assessment VAS as a covariate, which controls for the 
effect of a covariate and decreases the error. 
  
 37 
 
Chapter 4: 
 Results 
4.1 Participants: 
From the inception of the Saskatoon Chronic Pain Centre in Saskatoon in 
May, 2004, to the study cutoff date of October 2007, there were 417 clients 
considered eligible for this study. (Figure 4.1)  The research assistant, hired by 
the Saskatoon Health Region to make the initial phone calls, was able to contact 
214 of the 417 clients; 18 of those contacted declined the invitation to participate, 
5 were reported as deceased and 191 agreed to participate in the study. Of the 
remaining 203 clients, 39 had moved with no new contact information and 164 
had no answer at the contact phone number on file.   
 
 
Figure 4.1: CPC Population. 
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The total return response for the questionnaire package was 144, 
although one subject stated that he was refusing to complete the questionnaires 
and one subject  was deemed ineligible as she had actually only completed the 
six week program one month prior to the study. (the assessment date had been 
several months previous to this). The sample considered for this study included 
142 clients. (34%) It is worth noting, though, that from those 214 clients that were 
contacted 144 of them returned the questionnaire package. (67%) 
Based on data provided by the CPC on various characteristics, 
comparisons between the study participants and those not participating in the 
study are shown in Table 4.1 below.  Compared to the clients not included in the 
study, study participants were older and more likely to have attended the CPC 
treatment program.  There were no significant differences between participants 
and those not participating in the study based on gender, education level, area of 
pain or in the pre-admission VAS. 
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Table 4.1: Characteristics of Study Participants and Study Nonparticipants. 
 
 Study Participants 
(n=142) 
Clients not 
Participating in Study 
(n=275) 
 
 Mean SD Mean SD p 
Age 49.46  10.65 46.05  12.25 .005 
     Range 20 - 79  18 - 81   
Pre-Admission VAS   6.34   1.58   6.62   1.55 .101 
Time since assessment  (mo) 33.04 13.24 33.38 14.79 .878 
      
 Number % Number % p 
Gender:             
Male 53 37.32 99 36.00  
    Female 89 62.68 176 64.00 .790 
Education level:      
High School or less 51 35.92 101 36.73  
College/technical/ other course 54 38.03 116 42.18  
University /grad degree 25 17.60 40 14.55  
  missing 12   8.45 18   6.55 .623 
Area of Pain      
    Musculo-skeletal 105 73.94 212 77.09  
    Neuropathic 21 14.79 37 13.45  
    Other (combined) 16 11.27 26   9.45 .364 
CPC Treatment       
Yes 88 61.97 135 49.09  
No 54 38.03 140 50.90 .012 
 
 
 
 
4.2 Research Question I 
 
Are improvements in clients physical and social functioning, 
observed at completion of the six week program, maintained over time? 
 
This question pertains only to the treatment group; those clients 
participating in the study who had attended the six week CPC treatment program. 
(n=88) The outcome variables used for this analysis had been collected at three 
points in time, and Table 4.2 shows the mean scores and standard deviation for 
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the relevant dependent measures at each time point. Improvement is 
demonstrated by decreased scores for the BDI, Pain Intensity, Interference, and 
Affective Distress, and increased scores for Life Control. 
 
Table 4.2: Mean Scores on Outcome Variables for Treatment Group. (n=88) 
 
Outcome 
Variable 
 
Admission (CPC) 
scores 
Time 1 
Discharge CPC) 
scores 
Time 2 
Follow-up (Study) 
 scores 
Time 3 
 Mean SD Mean SD Mean SD 
BDI 22.88 10.38 15.43 10.30 19.90 11.91 
Pain Intensity 49.64  7.16 45.34   9.25 46.06 10.03 
Interference 52.72  6.20 49.14   7.73 51.04   8.26 
Life Control 49.27  8.16 55.58   8.74 52.24   9.37 
Affective Distress 50.43  8.43 45.54   8.72 46.61   8.89 
 
 
Results of the paired t-test are shown in Table 4.3. There was a 
statistically significant improvement for all dependent variables, between Time 1 
and Time 2, followed by a statistically significant  decline in scores between Time 
2 and Time 3 for three of the five outcome variables; BDI, Interference, and Life 
Control.   However, despite this decline between Time 2 and Time 3, the scores 
for all of the outcome variables still demonstrated an overall statistically 
significant improvement from Time 1 to Time 3 (from admission to follow-up).   
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Table 4.3: Treatment Group: Changes in Mean Scores.7 (n=88) 
 
 Time 1 - 2 p Time 2 – 3 p Time 1 – 3 p 
BDI Improved .001 Declined .011 Improved .001 
Pain Severity Improved .001 Declined .775 Improved .001 
Interference Improved .000 Declined .046 Improved .009 
Life Control Improved .001 Declined .002 Improved .004 
Affect Distress Improved .001 Declined .151 Improved .007 
 
The next step in analysis was multivariate analysis of covariance 
(MANCOVA), using the “difference scores” for Time 1 to Time 2 and Time 1 to 
Time 3.  Box’s test of Equality of Covariance Matrices was nonsignificant (Box’s 
M=97.79, p=.475), demonstrating that there was homogeneity of covariance of 
the dependent variables across all independent groups.  The results of the 
MANCOVA were consistent with the results of the paired t-test, demonstrating 
that the differences seen in the means at these levels were statistically 
significant. (Wilks’ Λ=.501, F(1,48)=4.788, p=.000).   This indicates that when 
looking at all the outcome variables simultaneously, the improvement in scores 
from admission to discharge, and from admission to study were statistically 
significant.   Other factors included in the analysis were Gender, Education Level, 
Area of Pain, and Further Treatment and the covariates examined were Age, 
Time Since Treatment and Pre-Admission VAS. There were no statistically 
significant main effects for any of these variables. The MANCOVA was repeated 
using the Time 1 scores as covariates rather than the “difference scores”, and 
produced consistent results. 
                                            
7 Outcome variables that were found to violate the assumption of normality in at least one level 
(Time1, Time 2 or Time 3) were transformed at all levels prior to analysis. 
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The MANCOVA did demonstrate a statistically significant interaction 
between gender and education level.  (Wilks’ Λ=.544, F(2,96)=1.709, p=.045).  
The univariate results show the interaction between gender and education level 
affecting only the Interference Time 1 to Time 2 scores.  (F(2,57)=7.161, p=.002)  
Looking at the changes in scores between Time 1 and Time 2, for males the 
most change occurred for those with a high school or less education, while for 
females the largest change occurred for those with a university or graduate 
degree.   
 
4.3 Research Question 2 
Is there a significant difference in these outcomes, on evaluation at 
least one year after assessment, of those clients who completed the six 
week program (treatment group) compared to those who underwent the 
initial assessment, but did not attend the program (control group)? 
 
 Demographics and pain-related assessment information for study 
participants, by treatment status, is shown in Table 4.4.  There were no 
statistically significant differences between the treatment and control groups 
based on Age, Gender, Education Level, Area of Pain, Pre-Admission VAS, 
additional treatment or time since assessment at the CPC.  Further examination 
of the information regarding additional treatment sought since contact with the 
CPC also did not demonstrate any significant differences between the treatment 
and control groups in the kinds of treatment that were reported. (acupuncture, 
biofeedback, chiropractic, physical therapy and other) 
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Table 4.4: Comparison of Treatment and Control Groups on Demographic and 
Assessment Data. 
 
 Treatment Group 
(n=88) 
Control Group 
(n=54) 
 
 Mean SD Mean SD p 
Age 49.16 10.03 49.94 11.66 .671 
     range 23-74  20-79   
Pre-Admission VAS   6.26   1.60   6.48   1.50 .481 
Time since assessment at CPC(mos)   32.99 13.41 33.11 13.10 .958 
      
 Number % Number % p 
Gender      
Male 32 36.36 21 38.89  
Female 56 63.64 33 61.11 .763 
Education level      
High School or less 30 34.09 21 38.89  
College/technical/other course 32 36.36 22 40.74  
University degree/grad degree 18 20.45 7 12.96  
     Missing 8  9.09 4   7.41 .488 
Area of Pain      
     Musculo-skeletal 66 75.00 39 72.22  
    Neuropathic 12 13.64 9 16.67  
    Other (combined) 10 11.36 6 11.11 .181 
Treatment since CPC      
    Yes  61 69.32 42 77.78  
    No 27 30.68 12 22.22 .319 
Note: the Pre-Admission VAS scores were transformed prior to analysis to correct for negative 
skew of scores. 
 
 
Preliminary data analysis included a series of one way ANOVA’s (Table 
4.5)  to examine the means and standard deviations of the eight outcome 
measures, (outcome variables for this question as listed in Table 3.1).for both the 
treatment and control groups.  No statistically significant differences emerged 
between the treatment and control groups for any of the variables.  
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Table 4.5: Means and Standard Deviation of Variables by Treatment Status. 
 
Note: actual score values are reported here, although transformed scores were used for analysis 
and establishing significance. 
 
 
Because there are eight dependent variables for research question 2, a 
multivariate analysis of covariance (MANCOVA) was undertaken.  Box’s test was 
nonsignificant (Box’s M=130.84, p=.547), indicating that the assumption of 
homogeneity of covariance matrices had not been violated.  No main effect was 
demonstrated for treatment condition, (Wilks’ Λ=.930, F (1,107) = 1.014, p=.430). 
There was also no interaction of treatment condition with any of the factors 
examined including Gender, Education Level, and Area of Pain or with any of the 
covariates which included Age, Time Since Assessment, Pre-Assessment VAS,.  
However, main effects did emerge for Pre-Assessment VAS (Wilks’ Λ=.756, 
F(1,107)=4.314, p=.000), Area of Pain (Wilks’ Λ=.692, F(2.214)=2.701, p=.001) 
and Education Level (Wilks’ Λ=.868, F(1,107)=2.030, p=.050).   
 Treatment Group 
(n=88) 
Control Group 
(n=54) 
 
 Mean SD Mean SD p 
VAS (pain rating)   5.64   2.28   5.63   2.53 .975 
BDI – total score  19.95 12.07 19.66 11.80 .888 
MPI – Pain Severity  45.55   9.48 46.95 10.98 .296 
MPI – Interference 50.95   7.69 51.11   9.26 .641 
MPI – Life Control 51.58   9.33 53.33   9.51 .284 
MPI– Affective Distress 47.07   8.31 45.71   9.81 .377 
MPI – General Activity 52.16   9.54 52.05 12.62 .953 
Global Change    3.27   1.50   3.77   1.63 .070 
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The univariate tests demonstrated the effect of Pre-Assessment VAS on 
all of the outcome variables except Affective Distress. (Table 4.6) 
 
Table 4.6: Between Subject Effects for Pre-Assessment VAS. 
 
 df Mean Square F p 
VAS (follow-up) 1 113.686 28.04 .000 
BDI (total) 1  10.609   5.37 .022 
Pain Severity 1         1.675 E7 28.13 .000 
Interference 1           3.885E10 12.69 .001 
Life Control 1 354.777   4.29 .041 
Affective Distress 1 168.498   2.16 .144 
General Activity 1 452.497   4.58 .035 
Global Change 1 2.192 14.14 .000 
 
To understand the effect that the Pre-Assessment VAS had on the scores 
for the outcome variables, a correlation matrix, presented in Table 4.7, was 
computed.  The Pre-Assessment VAS scores are positively correlated with the 
BDI, Pain Severity, Interference and Global Change, and negatively correlated 
with Life Control and General Activity.  Thus, a higher Pre-Assessment VAS was 
associated with poorer outcomes at the time of the study. 
Table 4.7: Correlation Matrix: Pre-Assessment VAS and Outcome Variables. 
 
 
 
VAS 
(study) 
BDI Pain 
Severity 
Interf. Life 
Control 
Affect. 
Distress 
General 
Activity 
Global 
Change 
Pearson 
Correlation 
.43 .28 .47 .37 -.23 .18 -.25 .35 
Sig (2-tail) .000 .001 .000 .000 .008 .036 .004 .000 
N 130 132 133 133 133 133 133 131 
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For Area of Pain and Education, looking at the between subject effects, 
both factors were seen to have an effect only on the Follow-up VAS scores.8  As 
shown in Table 4.8, those with musculoskeletal pain were highest, on average, 
on the VAS, and those with “other” scored lowest.  In regard to Education,9  VAS 
scores were higher for those participants with less formal education.  Although 
this is statistically significant, it is less than 1.0 point (1 cm on VAS) difference, 
which does not reach the level of minimally important clinical change. (40)   
 
 
Table 4.8: Effect of Area of Pain and Education Category on VAS. 
 
 n Mean 
VAS 
SD Standard 
error 
Mean 
square 
F p 
Area of Pain        
Musc-skeletal 102 5.83 2.27 .22    
Neuropathic 21 5.38 2.25 .49    
Other 16 4.69 2.96 .74 25.53 6.30 .003 
Education 
Category 
       
H.S/tech 81 5.75 2.33 .26    
Univ/diploma 58 5.47 2.44 .32 16.23 4.00 .048 
 
 
The VAS is the only variable that had been measured at the pre-
assessment stage as well as the follow-up for all study participants.  In an 
exploratory analysis, results of paired t-tests, (Table 4.9) conducted separately 
for the treatment and control groups revealed that both groups experienced a 
                                            
8 The test for homogeneity of variance for the outcome variable VAS was not met, (Levene’s 
p=.028) therefore, the results for this variable should be interpreted with caution.  Because 
ANOVA is quite robust, though, the results will be examined. 
9 The Education levels had been collapsed into two categories: 1) high school or less, some 
college, or technical school and 2) University degree, other diploma or certificate or Graduate 
degree.   
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statistically significant improvement in pain severity between pre-assessment and 
the time of the study.  
 
Table 4.9: Mean Change of VAS Scores by Treatment Status. 
 
 Mean pre-
assessment VAS 
Mean follow-up 
VAS 
Mean 
change 
p 
Treatment 
Group 
6.25 5.53 .72 .004 
Control Group 
 
6.44 5.53 .91 .007 
 
However, additional analysis, using an ANOVA to examine the difference scores, 
revealed no statistically significant difference in these scores, representing 
change over time, according to treatment status.(p=.646)  
To further compare the treatment and control groups on the Follow-up 
VAS, a univariate analysis of covariance (ANCOVA) was conducted.  Because 
the Pre-Assessment VAS is known to have an effect on the VAS, entering it as a 
covariate in the ANCOVA controls for its effect on the VAS, reducing error.  
Again, this test did not demonstrate any significant difference between the 
treatment and control groups based on the VAS. (p=.795) 
Further analysis then considered the question of Global Change. Although 
the mean Global Change score was 3.46 and there was no statistical difference 
found between treatment and control groups, it is important for the reporting of 
the results to examine the data by percentage breakdown, as well.  The results 
presented in Table 4.10 demonstrate that, overall, 59.3% reported feeling some 
degree of improvement, compared to 14.3% reporting no change and 26.4% 
stating that they were minimally, much or very much worse. 
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Table 4.10: Results of Global Change Question. 
 
 1 
=very 
much 
improved 
2 
=much 
improved 
3 
=min. 
improved 
4 
=no 
change 
5 
=min. 
worse 
6 
=much 
worse 
7 
=very 
much 
worse 
Treatment 
Group 
       
n (n=88) 7 25 25 9 13 8 1 
% 8.00 28.4 28.4 10.2 14.8 9.1 1.1 
Control 
Group 
       
n (n=52) 2 11 13 11 4 8 3 
% 3.7 20.4 24.1 20.4 7.4 14.8 5.6 
Total 
(n=140) 
       
n 9 36 38 20 17 16 4 
percent 6.4 25.7 27.1 14.4 12.1 11.4 2.9 
 
Finally, to more carefully examine the change in scores on some selected 
outcomes, the difference, or change in scores were computed for the variables 
and the mean changes are reported in Table 4.11. 
 
  Table 4.11: Mean Changes in Selected Outcome Scores. 
 
  
n 
Mean Change 
Time 1 - 3 
VAS 130 0.79 
Interference 
(treatment group only) 
73 1.89 
BDI 
(treatment group only) 
73 2.95 
 
The selected outcomes were chosen and discussed by the IMMPACT 
paper and the mean change in a variable is important in the determination of 
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clinically important change, which will be discussed in more detail in the next 
section.  
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Chapter 5: 
 Discussion 
Chronic pain is a common and important cause of reduced function in 
daily life.  Multidisciplinary treatment programs, although found to be the best 
choice of management, do not provide all the answers.  The goal of these 
treatment programs is not necessarily to improve the pain, but rather, to improve 
the coping skills and function of someone living with chronic pain. (34,35) 
Research has supported the effectiveness of a multidisciplinary approach to 
treatment of chronic pain, (7,8,10,14,16,36)  and  have reported improvement in 
function and lifestyle and improved coping strategies following treatment.  
Multidisciplinary treatment for chronic pain has been studied extensively, but 
questions remain about its long-term effectiveness.  The literature also clearly 
states that there are many issues related to the study of chronic pain; the lack of 
standard outcomes, difficulty in using adequate control groups and poor 
response rates which make it difficult to compare the different studies.  The lack 
of follow-up longer than one year has also been identified as an issue that needs 
more investigation to determine effectiveness. 
  This study was specifically designed to re-evaluate the CPC clients at 
least one year following their completion of the treatment program to determine if 
they had maintained improvements in function and social well-being observed at 
the completion of the six week program.  A second goal was to examine how 
they compared to the group of clients who had undergone initial multidisciplinary 
assessment at the Centre, but did not attend the six week treatment program.  
The main findings of this study were: 
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1) The scores on the outcome measures for the treatment group did 
improve significantly during the six week treatment period, and although there 
was some decline in the scores, they remained significantly improved at the time 
of this follow-up study (between one and three years since treatment) compared 
to admission; and  
2) There were no statistically significant differences on any of the outcome 
measures between the treatment and control groups at the time of the follow-up 
study.   
 With respect to the first research goal of this study, the data confirmed 
that the clients who had attended the six week treatment program demonstrated 
a statistically significant improvement in all the outcome variables following the 
program.  This is supported by the CPC’s internal report and in the literature by 
several other studies.  Dysvik (34) looked at data immediately following a 
multidisciplinary treatment program; Mead et al (16)  used data from six weeks 
post program, and Moss-Morris et al (36) evaluated patients at the end of a 
treatment program as well as a one, three and six months.  These authors all 
found participation in a multidisciplinary treatment program to be associated with 
significant improvement in various measures of physical and social well-being.  In 
the present study, since there is no control group for this period, we must be 
cautious suggesting causation, as alternate explanations may be possible for the 
findings. For example, measurement bias- if clients as part of the study tend to 
give more socially acceptable answers or perhaps attention bias – if clients who 
are part of the study give more favourable responses as a result of the attention 
received.  However, the significant improvement in all measures over such a 
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short period of time does suggest a positive impact of the treatment program.  
Although scores did decline over time they did not return to the pre-treatment 
level and the improvement remained statistically significant.  This decline over 
time has been observed and discussed in the literature as well.  A study 
conducted in Finland in 1990 (53) found that improvements noted at three 
months after a treatment program had “faded out” in many of the measured 
parameters after one year.  Lanes et al (12) and Bendix et al, (54) in evaluating 
chronic back pain treatment programs, found a decline in improvement as they 
moved to longer term, and Moss-Morris et al (36) showed losses in treatment 
gains over a six month follow-up period.  In fact, it has been suggested that a 
“booster” treatment might be effective in an effort to counter the decline in scores 
over time. (12,53,54) 
Regarding the second goal, it was surprising, given the significant 
improvement of the treatment group on all outcome measures, to see no 
significant differences between the treatment and control groups on any of the 
variables at the time of the study follow-up.  It is difficult to compare these 
findings to other studies due to the issues discussed previously.  However, 
Deardorff, (15) did find that both treatment and control groups showed significant 
improvement  in pain ratings and the “interference with activities ratings” at a 
follow-up period averaging 11 months, but they also found that the treatment 
group showed significant improvement compared to the controls on several other 
measures as well.  There are few studies that look at follow-up longer than 12 
months, and those that do have used a wide variety of measures and few have 
used control groups.  McCracken and Turk (10) conducted a literature review, 
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which included several meta-analyses, and concluded that “there was little data 
beyond 18 months.”  There are some longer term studies that look specifically at 
back pain treatment.  Bendix et al (54) did a 5 year review of subjects and found 
positive results in the treatment group compared to the control group related to 
sick time use and health care usage, but no differences for all other parameters 
studied.  A systematic review done in 1999 looking at multidisciplinary 
rehabilitation in fibromyalgia and widespread musculoskeletal pain (70)  found 
limited research-based evidence favouring multidisciplinary rehabilitation.  They 
stated “Despite an extensive search we were able to select only seven relevant 
trials to include in this systematic review” and that “the methodological quality of 
the selected studies was low.”  These authors go on to report that they found “no 
quantifiable benefit of multidisciplinary rehabilitation for fibromyalgia. However, 
behavioural treatment and stress management appear to be important 
components of multidisciplinary rehabilitation. Education combined with physical 
training produced some positive effects in long-term follow-up.” 
Due to methodological constraints, the lack of difference between the 
treatment and control groups in our study is not easily explained.  That is, 
although we were able to follow the treatment group over time, we had no 
equivalent information for the control group; thus, the comparison between the 
treatment and control groups was based on data collected at only one point in 
time.  
The only exception was the VAS, which was administered to both control 
and treatment participants at two points in time (CPC Pre-Assessment and the 
Follow-up questionnaire). As reported in Table 4.4, there was no statistically 
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significant difference between the treatment and control group in Pre-Admission 
VAS or in the Follow-up VAS (Table 4.5).  Analysis revealed that both groups 
experienced a statistically significant improvement in pain severity (Table 4.9) 
and there was no statistically significant difference in the change over time 
according to treatment status. This would suggest that both the treatment and 
control groups demonstrated a similar degree of improvement between these two 
points in time.  
Examination of the average scores the VAS at different lengths of time 
since assessment also suggests that the control group may have gradually 
improved over time.  The graph below (Figure 5.1) shows the average scores for 
the treatment and control groups on the Follow-up VAS categorized by time since 
assessment. (those less than and greater than the median time of 32 months.)  
For those in the treatment group, there was no statistically significant association 
between time since assessment and study VAS scores. For the control group 
however, participants reporting at a longer time since assessment had 
significantly better VAS scores than those reporting less time since assessment 
(p. = .04). While the treatment group demonstrated rapid improvement between 
admission and discharge, which was largely maintained to the time of the study, 
(Research Question 1) the improvement of the control group may have been 
more gradual over time. 
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Figure 5.1: VAS Average Scores by Time Since Assessment. 
 
 
 
As there are no pre-assessment data for the control group for any of the 
other variables, there is no baseline to establish whether they improved over time 
or not.  A similar pattern of scores presented for the VAS, based on length of 
time from assessment, was observed for the Pain Severity (difference in control 
group scores: p=.003) and for Interference scales of the MPI (difference in 
control group scores: p=.01). (Data not shown)  It is important to note these 
results do not illustrate changes over time, but rather cross-sectional differences 
based on length of time since assessment.  However, they do represent 
significant differences, and illustrate a trend that may assist in the interpretation 
of results.  Although it cannot be stated that this represents improvement in 
scores over time, the trend observed in multiple outcome measures may suggest 
such.  This would support the findings of Deardorff, (15) who reported significant 
improvement in pain ratings and “interference with activity ratings” for both the 
treatment and control groups.  On the other hand, as these are not repeated 
measures, the “greater than 32 months” group of clients may have had 
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significantly better scores from the beginning, and rather than improving over 
time, may have merely maintained these scores. 
An important issue to consider is the clinical importance or 
meaningfulness of the change in scores that is being analyzed.(40)  Although 
many studies demonstrate statistically significant changes, there has been very 
little work done on determining what reflects a clinically important change.  The 
IMMPACT consensus meeting developed recommendations for determining 
clinical change for chronic pain outcome measures and noted that “patients, 
clinicians, third-party payors and others may have very different perspectives 
regarding what benefits constitute clinically important improvement.”(40)  The 
group also stated that clinically important change in individuals cannot be directly 
applied to the evaluation of group differences, but do go on to propose 
“provisional benchmarks” for comparing different treatment groups within trials.  
For the VAS they suggest that a reduction of at least 10%-20% (1-2 cm.) reflects 
minimally important change.  As reported previously in Table 4.9, the mean 
difference in VAS scores is less than 1 cm for both the treatment and controls, 
which may mean that the changes demonstrated, although statistically 
significant, may not represent a meaningful clinical change.  Having said that, it is 
important to remember that the primary goal of treatment is not necessarily to 
reduce the pain, but rather, to improve the coping skills and functioning of those 
living with chronic pain, so changes in the VAS alone cannot be used to evaluate 
improvement.  
In discussion of clinical importance for the domains of physical and 
emotional functioning, the IMMPACT discussion used the MPI Interference scale 
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and the BDI respectively, both of which were used in this study for analysis of 
changes in the treatment group over time. The IMMPACT paper suggests a 
change of 0.6 points on the Interference scale and 5 points on the BDI could be 
considered a reasonable estimate of a clinically important change. (40)   Looking 
at the mean change in the Interference and BDI scores presented in Table 4.11, 
a clinically important change is noted for Interference (mean change=1.89), but 
the change in the BDI score (mean change = 2.95) does not quite meet the 
suggested level for minimal clinical change. 
Due to the low response rate and issues with method of recruitment 
(recruitment issues discussed under limitations) these results need to be 
interpreted with caution, but it does highlight the need to examine clinical 
relevance in future studies. 
The only measure of whether or not the subjects feel they have improved 
or not is the Global Change question, which provides an indication of clients 
overall impression of change. (38)  The measure has been criticized due to 
reliance on the participant recalling their initial state and mentally comparing it to 
the present, which, for some subjects was three years, but it does offer a 
measure of the participant’s personal perspective. (38)  Although on a 0 to 7 
scale, the mean score for Global Change was 3.46 (SD 1.56) which corresponds 
to the descriptor “No Change”, the actual percentage of responses in the 
categories is important to note. The results demonstrate that, overall, 59.3% 
reported feeling minimally, much or very much improved, compared to 14.3% 
reporting no change and 26.4% stating that they were minimally, much or very  
much worse.   
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5.1: Other findings: 
The present study did demonstrate that the Pre-Admission VAS was a 
statistically significant predictor for all the outcome variables, except for Affective 
Distress. A higher Pre-Assessment VAS was associated with poorer outcomes at 
the time of the follow-up.  Therefore, those experiencing more severe pain at pre-
admission reported higher levels of depression, more intense pain, increased 
symptoms of depression, less sense of life control, lower general activity and 
more interference of pain with everyday activities at the time of the study.  Using 
the Pre-Admission VAS score could provide an additional tool for the CPC to 
allow for modification or stratification of the treatment program based on this 
predictor. 
  
5.2 Study Strengths and Limitations 
The purpose of this study was to evaluate the long term outcomes of the 
Saskatoon CPC treatment program, and an effort was made to address a 
number of methodological gaps identified in the literature.  The outcome 
measures used in this study were those that were previously used by the CPC as 
well as having been recommended by IMMPACT (39), which will provide easier 
integration with other studies using these standardized measures.  Although 
other measures might better capture certain aspects of chronic pain such as self 
efficacy, it was felt that an important part of this study was the effort to utilize the 
standardized assessment tools recommended by IMMPACT.   
A control group, although not randomized, was used to provide 
comparison for the treatment group, and comparison of these groups was done 
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on several pre-assessment factors.  In addition, a number of recommended 
techniques were employed to improve the response rate. To address the issue of 
longer term follow-up, this study looked at clients at least one year after their final 
contact with the CPC.  This provided data over a three year follow-up period, as 
opposed to the more common six to twelve month reviews.  The longer period of 
follow-up may have contributed, though, to the difficulty in contacting subjects, as 
no effort had been made by the CPC to maintain current contact information. 
There are limitations of this study.  The first limitation is the fact that the 
treatment and control groups were not randomized.  The clients self-selected 
whether to attend the treatment program, and although comparison between the 
treatment and control groups on a number of characteristics was possible and 
revealed few differences, there is still a risk of selection bias.  It is possible that 
the groups differed on factors that were not measured which may have impacted 
the outcomes of interest in the study. 
The second limitation is the lack of “pre-test” scores.  Given that the 
program was not designed to collect the test variables prior to the start of the 
treatment, there was a limited amount of comparative data for the treatment and 
control groups. The data available did not demonstrate any significant differences 
in demographics, area of pain or pre-admission VAS levels of pain, but 
comparison on complete “pre-test” information was not possible.  Even given 
these limitations, there are a number of factors which suggests that the treatment 
and control groups were likely similar on key factors.  First, all CPC clients had 
been screened at 3 levels: by a family physician, by the CPC at the referral stage 
and again at the pre-assessment stage.  At each of these stages, those clients 
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who were not compatible for the program were re-directed elsewhere.  This 
screening process would increase the likelihood that the group of clients as a 
whole (both those who completed the program and those who did not) were 
similar on characteristics potentially related to the outcomes of interest.  
Secondly, for all clients, there is a considerable amount of data gathered during 
the pre-assessment and assessment period. To address the lack of a “pre-test” 
score for the control group on key outcome measures, the two groups were 
compared on a number of variables collected at the pre-assessment and 
assessment stage to establish similarity in these populations.  This comparison 
not only included Age, Gender and Educational Status but also, Pain Severity 
(Pre-Admission VAS) and Area of Pain.  Thirdly, to respond to a concern about 
the differences in populations that could result in self-selection to a particular 
group, a survey conducted by the CPC10 asked the question why clients did not 
attend the treatment program and found that the primary reason was travel 
distance, time, and costs involved in hotel, food, travel, etc. for the six week 
treatment period.  Because the Saskatoon CPC is a publicly funded program, 
there is no cost to the client for the treatment program itself.  This likely 
introduces less bias than the control groups used in the literature that were 
based on drop-outs, or lack of insurance or ability to pay for treatment programs.    
A third limitation was response rate, which has been discussed as a 
problem with chronic pain research as it is a difficult population to engage.  It is 
not uncommon to see studies based on less than 30 % of the original population. 
(17)  Nonresponse bias can lower statistical power, mask statistically significant 
                                            
10 Saskatoon Chronic Pain Centre, internal review. 2006 
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relationships which “truly” exist and limit the generalizability of the findings. (49)  
In this study, from the 417 clients determined to be eligible for this study, data 
was collected for 142 of them (34%), although it is worth noting that 144 of the 
214 clients that were contacted ( 67%) did respond to the questionnaires.  
Because nonresponse bias is a risk, comparison was done between those who 
participated in the study with those who did not.  It showed that at the time of 
their pre-admission assessment by the CPC, they did not significantly differ in 
Gender, Education Level, Area of Pain or Pre-Admission rating of pain intensity.  
They also did not differ on the average Length of Time since contact with the 
CPC.  However, study participants and clients who did not participate in the study 
did differ significantly on Age, with the study participants being older, and on 
treatment status, with a higher percentage of the study participants having 
attended the six week treatment program 
 A fourth limitation is related to the method of recruitment.  Due to 
“privacy” concerns, the initial contact with all CPC clients was done by personnel 
hired by the Saskatoon Health Region. Because virtually all of the contact phone 
calls were made during regular working hours (8:00 A.M. to 6:00 P.M.) there may 
have been an impact on the response, as those who were working would be 
unavailable and therefore not invited to participate in the study. This may have 
significantly skewed the results if those clients whom they were unable to reach 
were, in fact, the clients who had made the most improvement and had returned 
to work, leaving those who were retired, or not at work as a larger part of our 
study population.  Response rates could potentially be improved by continued 
tracking of clients by the CPC, to maintain current contact information as well as 
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ensuring that contact phone calls, to recruit participants, were made at various 
times throughout the day as well as on weekends. 
And finally, due to time and financial constraints, the study was cross-
sectional rather than longitudinal which limited the ability to examine the changes 
in scores over time.  Although the study data was collected for all participants at 
least one year since contact with CPC, the time period varied by participant 
between one and three years.  Data was available for three different time periods 
for the treatment group, the first two being admission and discharge of the 
treatment program, but the third, at the point of follow-up data collection, also 
varied from one to three years.  
 
5.3 Significance of the Study 
The findings of this study contribute to the chronic pain treatment literature 
by examining longer term outcomes than have generally been the case and by 
the use of a control group.  Although this study lacked standardized pre-test 
scores it was demonstrated that the treatment and control groups were similar by 
comparison on multiple factors at the pre-treatment stage.  Although the quasi-
experimental design does not allow for causal inferences to be made, 
demonstrating a statistically significant improvement over a short time period 
among treatment participants, which is largely maintained over time, does 
strengthen the inference that the treatment program has a positive impact.  
Statistically significant improvements, however, need to be studied in more depth 
to determine clinical importance.  The fact that there was no difference between 
the treatment and control groups at follow-up is more difficult to interpret and 
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supports the need for more long-term studies using a control group that is 
followed over time. Even given the limitations, this study provides valuable 
information both to the research literature and to the agency, which is interested 
in to having some indication of the long-term effects of their program. 
 
5.4 Conclusions 
This study demonstrates that the scores on all the outcome variables did, 
in fact, improve significantly from the time of assessment to the time of discharge 
for the clients who had attended the CPC program.  These improvements were 
seen to decline for all variables over time, although not significantly for the scales 
of Pain Severity and Affective Distress.  Even with the decline in scores, the 
study scores remained significantly improved from the admission scores. 
 Having said that, the study also found that overall there were no significant 
differences between the treatment group and the control group at the time of 
follow-up on any of the outcome measures.  Although this is difficult to explain, 
especially given the limitations of this study, it is possible that there may be a 
gradual improvement over time, especially evident in the pain intensity scores, in 
those clients who did not attend the treatment program.  Whether or not these 
improvements demonstrate clinical importance is also unclear.  The Global 
Change question also suggests improvement in both the treatment and control 
groups as the results demonstrate that 59.3% of the study participants reported 
feeling minimally, much or very much improved.  The findings in this study may 
have been affected by the recruitment process, in that clients who had 
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demonstrated more improvement may have been at work and therefore not 
contacted or included in this study.   
Time from assessment or treatment to follow-up may be an important 
factor, but as this study was a cross-sectional rather than a longitudinal design, 
the effects of time were not captured effectively.   Further study needs to look at 
changes in scores over time in a longitudinal design.  As well, the IMMPACT 
recommendations for evaluation focuses on outcomes but examination of 
treatment processes might assist in explaining outcome findings. Process-
orientated measures such as self-efficacy and active vs. passive coping might 
add depth in capturing the goals of the CPC treatment program. 
In terms of the Saskatoon CPC program, the study confirmed that the 
clients did improve significantly over the six week treatment period, which does 
suggest a positive impact of the program.  Further study needs to be done to 
examine clinical importance.  It is also clear that the Pre-Admission VAS is, 
statistically, a predictor of outcome, and perhaps could be used to modify or 
stratify the treatment program to address various levels of pain intensity.  The 
suggestion of a “booster” program should be considered in light of the finding that 
the scores on the outcome measures for the treatment group did decline over 
time.  Finally, maintaining current contact information for clients for follow-up and 
inclusion of some or all of the assessment battery at the time of pre-admission 
would greatly enhance future evaluation as it would potentially improve the 
response rate as well as provide additional information for comparison for the 
control group 
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Appendix 7.1 
 
Pre-Assessment and Assessment information: 
 
Demographic Data: 
o Age 
o Sex 
o Education level 
o Employment status 
o Income level 
o Income source (ie salary, WCB, pension) 
 
Past Medical history 
o Past medical/surgical history 
o Other symptoms (ie nausea, dizziness, memory difficulties) 
 
Social history: 
o Lives alone/with partner/children 
o Alcohol/”street” drug use 
o Smoker/non-smoker 
 
Pain history: 
o Date of onset  
o Cause of pain 
o Pain rating on scale of 0 to 10. (VAS) 
o Other treatments sought for relief of pain 
 
Emotional Functioning: 
o Anxiety / Depression 
o Change in relationship with partner ( scale of 0 to 10) 
 
Physical Functioning / Interference: 
o Sleep disturbance  
o Fatigue 
o Memory/concentration 
o Sitting/standing/walking tolerance 
o Sexual difficulties 
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Appendix 7.2 
 
Saskatoon Chronic Pain Centre Study 
Return Address 
Date 
Re: An Evaluation of the Long-Term Treatment Outcomes of a Multidisciplinary 
Chronic Pain Centre Program. 
 
Dear__________________________; 
 
You are being invited to participate in this research project because you were assessed at 
the Saskatoon Chronic Pain Centre in the past.  You may or may not have attended the 
six week program offered there. 
 
We are interested in knowing how you have changed, over time, in both the intensity of 
pain you are experiencing and your ability to cope and manage activities in daily life.  
The purpose of this study is to compare the changes in the group of clients who attended 
the program to the changes in those who were assessed but did not attend the program.  
We are hoping to gain information about what the effects are of attending the six week 
pain management program offered at the Saskatoon Chronic Pain Centre.   
 
Your participation is completely voluntary; you are not obliged to participate.  If you do 
agree to participate, you may choose to have your name entered into a draw for one of 
four digital cameras, as a token of our appreciation.  If you wish to enter the draw, please 
complete the attached entry form, seal it in the enclosed envelope, and return it with the 
completed questionnaires.  The entry envelope will be removed from the questionnaire 
when we receive them, and entered into the draw box.  Your questionnaire information 
will remain confidential. 
 
The following questions will help us to evaluate any changes, from your perspective, in 
your pain and ability to manage daily activities.  It will take approximately 15 to 20 
minutes to complete these questions.  Some of these questionnaires you may have seen or 
completed in the past.  
 
Please read the instructions for each section and indicate how that specific question 
applies to you.  Please do not write your name or any identifying information on the 
questionnaire sheets. 
 
Thank you for taking the time to assist us with this project. 
Yours truly, 
 
Flo Wagner 
   Flo Wagner 
   Masters Candidate, 
   Community Health & Epidemiology 
   University of Saskatchewan 
   (306) 966-2110 
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       ID # ____________ 
 
1)  Select the number below that best describes your pain during the past 24 
hours: 
 
 
0      1       2       3   4       5       6       7      8       9      10 
No        worst pain 
Pain        possible 
 
 
2)  Have you received any treatment for your pain since attending the Saskatoon 
Chronic Pain Centre?         No    □    Yes   □        (if yes, please check all that 
apply) 
   
  Acupuncture   □ 
  Biofeedback   □ 
  Chiropractic   □ 
  Physiotherapy  □ 
  Other    □  
       Please list other treatment:_____________________________ 
 
________________________________________________________________ 
 
________________________________________________________________ 
 
 
3)  Since your assessment at the Saskatoon Chronic Pain Centre, how would 
you describe the change (if any) in ACTIVITY LIMITATIONS, SYMPTOMS, 
EMOTIONS and OVERALL QUALITY OF LIFE, related to your painful condition? 
(check ONE box) 
  Very much improved □1 
  Much improved  □2 
  Minimally Improved  □3 
  No change   □4 
  Minimally worse  □5   
  Much worse   □6 
  Very much worse  □7 
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4)  Employment and Income Information: 
 
What is your current 
occupation?______________________________________________ 
 
Are you currently working?   □ Full time          □ Part-time         □ Not currently 
working.  
 
If not currently working, for how long have you been unable to work? 
 
      ________years and _______months 
 
 
 
 
 
5)  Household Income (OPTIONAL): (please circle one response) 
 
< $5,000   $20,000-$29,000  $50,000-$59,999 
 
$5,000-$9,999  $30,000-$39,999  >$60,000 
 
$10,000-$19,000  $40,000-$49,999  not provided 
 
 
 
 
 
 
6)  Income Source (Please circle all that apply) 
 
Salary    Worker’s Compensation Support for Independence 
         (Social Assistance) 
Employment Insurance Disability Pension (employer)   
 
Work Pension  Canada Pension Disability 
 
Other____________________________________________________________  
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         ID # ____________ 
 
MULTIDIMENSIONAL PAIN INVENTORY (MPI) 
 
Instructions:  An important part of our evaluation includes examination of pain 
from your perspective because you know your pain better than anyone else.  The 
following questions are designed to help us learn more about your pain and how 
it affects your life.  Under each question is a scale to mark your answer.  Read 
each question carefully and then circle a number on the scale under that 
question to indicate how that specific question applies to you.  An example may 
help you to better understand how you should answer these questions. 
 
Example- How nervous are you when you ride in a car when the traffic is heavy? 
 
  0            1            2            3           4            5            6 
    Not at all               Extremely 
    Nervous              Nervous 
If you are not at all nervous when riding in a car in heavy traffic, you would want 
to circle the number 0.  If you are very nervous when riding in a car in heavy 
traffic, you would then circle the number 6.  Lower numbers would be used for 
less nervousness, and higher numbers for more nervousness. 
  
Section I 
 
1. Rate the level of your pain at the present moment. 
 
    0            1            2            3            4            5            6 
       No pain                Very intense  
          Pain 
2. In general, how much does your pain interfere with your day-to-day activities? 
 
  0            1            2            3           4            5            6 
     No interference            Extreme interference 
 
3. Since the time your pain began, how much has your pain changed your ability 
to work? 
     ( ____  Check here if you have retired for reasons other than your pain.) 
 
  0            1            2            3           4            5            6 
   No change              Extreme change 
 
4. How much has your pain changed the amount of satisfaction or enjoyment you 
get from taking part in social and recreational activities? 
 
  0            1            2            3           4            5            6 
   No change              Extreme change 
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5. How supportive or helpful is your spouse (significant other) to you in relation to 
your pain? 
 
  0            1            2            3           4            5            6 
    Not at all              Extremely supportive 
            supportive  
 
6. Rate your overall mood during the past week. 
 
  0            1            2            3           4            5            6 
         Extremely low             Extremely high 
 
7. How much has your pain interfered with your ability to get enough sleep? 
 
  0            1            2            3           4            5            6 
       No interference             Extreme interference 
 
8. On the average, how severe has your pain been during the last week? 
 
  0            1            2            3           4            5            6 
       Not at all severe               Extremely severe 
 
9. How able are you to predict when your pain will start, get better, or get worse? 
 
  0            1            2            3           4            5            6 
        Not at all able             Very able to predict 
 to predict 
 
10. How much has your pain changed your ability to take part in recreation and 
other social activities? 
 
  0            1            2            3           4            5            6 
  No change               Extreme change 
 
11. How much do you limit your activities in order to keep your pain from getting 
worse? 
 
  0            1            2            3           4            5            6 
  Not at all              Very much 
 
12. How much has your pain changed the amount of satisfaction or enjoyment 
you get from family-related activities? 
 
  0            1            2            3           4            5            6 
  No change              Extreme change 
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13. How worried is your spouse (significant other) about you because of your 
pain? 
  0            1            2            3           4            5            6 
     Not at all worried              Extremely worried 
 
14. During the past week, how much control do you feel that you have had over 
your life? 
  0            1            2            3           4            5            6 
 No control               Extreme control 
 
15. On an average day, how much does your pain vary (increase or decrease)? 
 
  0            1            2            3           4            5            6 
    Remains the same               Changes a lot 
 
16. How much suffering do you experience because of your pain? 
 
  0            1            2            3           4            5            6 
         No suffering                 Extreme suffering 
 
17. How often are you able to do something that helps to reduce your pain? 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
18. How much has your pain changed your relationship with your spouse, family, 
or  significant other? 
 
  0            1            2            3           4            5            6 
 No change              Extreme change 
 
19. How much has your pain changed the amount of satisfaction or enjoyment 
you get from work? ( ____ Check here, if you are not presently working.) 
 
  0            1            2            3           4            5            6 
 No change              Extreme change 
 
20. How attentive is your spouse (significant other) to you because of your pain? 
 
  0            1            2            3           4            5            6 
    Not at all attentive              Extremely attentive 
 
21. During the past week how much do you feel that you’ve been able to deal 
with your problems? 
 
  0            1            2            3           4            5            6 
 Not at all                 Extremely well 
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22. How much control do you feel that you have over your pain? 
 
  0            1            2            3           4            5            6 
      No control at all          A great deal of control 
 
23. How much has your pain changed your ability to do household chores? 
 
  0            1            2            3           4            5            6 
 No change              Extreme change 
 
24. During the past week how successful were you in coping with stressful 
situations in your  life? 
 
  0            1            2            3           4            5            6 
  Not at all successful                 Extremely successful 
 
25. How much has your pain interfered with your ability to plan activities? 
 
  0            1            2            3           4            5            6 
 No change              Extreme change 
 
26. During the past week  how irritable have you been? 
 
  0            1            2            3           4            5            6 
    Not at all irritable                 Extremely irritable 
 
27. How much has your pain changed or interfered with your friendships with 
people other than your family? 
 
  0            1            2            3           4            5            6 
 No change              Extreme change 
 
28.  During the past week  how tense or anxious have you been? 
 
  0            1            2            3           4            5            6 
 Not at all tense       Extremely tense  
      or anxious           and anxious 
 
Section II 
 
Listed below are 19 common daily activities.  Please indicate how often you do 
each of these activities by circling a number on the scale listed below each 
activity.  Please complete all 19 questions. 
1. Wash dishes. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
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2. Mow the lawn. ( ____ Check here if you do not have a lawn to mow.) 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
3. Go out to eat. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
4. Play cards or other games. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
5. Go grocery shopping. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
6. Work in the garden. ( ____ Check here if you do not have a garden) 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
7. Go to a movie. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
8. Visit friends. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
9. Help with the house cleaning. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
10. Work on the car. ( ____ Check here if you do not have a car.) 
 
  0            1            2            3           4            5            6 
       Never               Very often 
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11. Take a ride in a car or bus. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
12. Visit relatives. ( ____ Check here if you do not have relatives within 160 km.) 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
13. Prepare a meal. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
14. Wash the car. ( ____ Check here if you do have a car.) 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
15. Take a trip. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
16. Go to a park or beach. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
17. Do the laundry. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
18. Work on a needed household repair. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
 
19. Engage in sexual activities. 
 
  0            1            2            3           4            5            6 
       Never               Very often 
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APPENDIX 7.4   RESEARCH PARTICIPANT INFORMATION and CONSENT FORM       
 
You are invited to participate in a research project entitled: An Evaluation of the Long-
Term Treatment Outcomes of a Multidisciplinary Chronic Pain Centre Program. 
 
Purpose: The purpose of this study is to evaluate what effect, if any, the six week 
program offered at the Saskatoon Chronic Pain Center has on levels of pain and ability to 
manage activities of daily living over a period of time.  You are being invited to take part 
in this research study because you have been assessed at the Chronic Pain Centre in the 
past, and may or may not have attended the six week program.  We would like to 
compare the responses of those who did attend with those who did not attend this six 
week program to see what differences there are in the way you have managed your 
chronic pain condition.  
 
Procedures:  If you agree to be part of this study, you will be asked to complete several 
questionnaires that will be sent to you by mail.  Some of these questionnaires you will 
have seen before as part of your assessment at the Chronic Pain Centre.  It will take 
approximately 15 to 20 minutes of your time to complete these. There will be a stamped 
envelope included for you to return the questionnaires. 
 
Some of the information you provide may be compared to the answers you gave during 
your initial assessment at the Chronic Pain Centre to determine if there has been any 
change in your condition.  This information will only be identified and linked by using 
your ID number, not your name.   
 
If you agree to participate, I will date and sign a consent form noting that I have read and 
explained the contents to you. 
 
Potential Benefits: We hope that the information learned from this study can be used in 
the future to benefit other people with chronic pain. If you wish to have a written 
summary of the results of the study, a summary will be mailed to you after the study if 
finished. 
 
As a token of appreciation for your participation, on receipt of your completed 
questionnaires, your name will be entered into a draw for one of four digital cameras.  An 
entry form and envelope will be provided and to ensure your response remains 
confidential, the sealed envelope will be removed from the returned questionnaires on 
receipt and entered into the draw box.  
 
Potential Risks: There are no known risks that are associated with the procedures 
described above.  Some of the questions are personal in nature.  You may refuse to 
answer any individual question.   
 
Storage of Data:  All study results and materials will be safeguarded and securely stored 
by the researcher in secure location and a locked file cabinet.  All results will be 
identified only by the ID number and the ID numbers will be stored separately from the 
master list of names to safeguard the identification of any individuals.  Once data 
 87 
 
collection is complete, the master list will be destroyed.  Data will be kept for five years 
and then destroyed in a secure manner. 
 
Confidentiality:  Your name will not be attached to any information, nor mentioned in 
any study report, nor be made available to anyone except the researcher.  The information 
that you provide will be entered into a database along with all other participants, and 
reports will be based on the summary of these findings.  What we learn from this study 
may be published or presented at conferences; but will be reported in summary form and 
no names will be used, so that it will not be possible to identify any individuals.  Also the 
Consent Forms will be stored separately from the questionnaires so that it will not be 
possible to associate a name with any given set of responses.  Please do not put your 
name or other identifying information on the questionnaires.  
 
Right to Withdraw:  Your participation is voluntary, and you can answer only those 
questions that you are comfortable with. If you agree to participate in this study, you are 
still free to withdraw at any time and without giving any reasons for your decision. There 
will be no penalty or loss of benefits to which you are otherwise entitled, and your future 
medical care will not be affected.  
 
Questions: If you have any questions concerning the research project, please feel free to 
ask at any point; you are also free to contact the researcher at the number provided if you 
have other questions.  This research project has been approved on ethical grounds by the 
University of Saskatchewan Behavioural Research Ethics Board on (insert date).  Any 
questions regarding your rights as a participant may be addressed to that committee 
through the Ethics Office (306 966-2084).  Out of town participants may call collect.   
 
Consent to Participate:   
 
I read and explained this Consent Form to the participant before receiving the 
participant’s consent, and the participant had knowledge of its contents and appeared to 
understand it. 
 
A copy of this consent form will be mailed to the participant. 
 
 
___________________________________   
 (Name of Participant)     
 
___________________________________ ________________________     _______ 
(Signature of Researcher)    (Date)         (Time) 
 
 
Please mail a written summary of the results of this study.   
Researcher:   Flo Wagner 
   Masters Candidate, 
   Community Health & Epidemiology 
   University of Saskatchewan   (306) 966-2110 
